Literature DB >> 9566641

QT interval and QT dispersion in systemic sclerosis (scleroderma).

A Sgreccia1, S Morelli, L Ferrante, C Perrone, P De Marzio, G De Vincentiis, F Scopinaro.   

Abstract

OBJECTIVES: To measure QT interval and QT dispersion, and to evaluate possible relationships between these measurements, heart rate variability parameters, and early myocardial involvement in patients with systemic sclerosis (SSc).
DESIGN: Prospective study.
SETTING: Tertiary care centre, University 'La Sapienza', Rome, Italy.
SUBJECTS: Thirty-eight patients with SSc (35 females and three males, mean age 47 +/- 11 years), 19 patients with the diffuse form of disease and 19 with the limited form, and 17 healthy controls (11 females and six males, mean age 43 +/- 10 years) were studied.
INTERVENTIONS: Both patients and control subjects underwent resting 12-lead electrocardiogram and 24-hour Holter monitoring. Moreover, resting myocardial scintigraphy with 99 m Tc-sestamibi was performed in all SSc patients. MAIN OUTCOME MEASURES: Bazett's formula was used to obtain rate corrected value of QT interval (QTc). QT and QTc dispersion were defined as the difference between maximum and minimum QT or QTc interval, respectively. Twenty-four-hour heart rate variability was analysed both in the frequency and in the time domain.
RESULTS: Twenty-three SSc patients (60.5%) had myocardial resting perfusion defects (group A) and 15 (39.5%) did not (group B). Maximum QTc interval, QT and QTc dispersion were significantly increased in SSc patients compared to the control subjects. No significant differences between group A and group B were observed for all QT measurements. Furthermore, maximum QTc interval, QT dispersion and QTc dispersion were significantly increased in group A patients compared to the control group. Total power, low-frequency, and high-frequency values were significantly lower in all SSc patients, whether in group A or group B, than in control subjects. On the other hand, low-frequency/high-frequency ratio was similar in all groups. Heart rate variability in time domain analysis showed no statistically significant differences between groups.
CONCLUSIONS: Patients with SSc have increased QTc interval, QT dispersion, and QTc dispersion. The role of autonomic nervous system and myocardial involvement on ventricular repolarization in patients with SSc needs further investigation.

Entities:  

Mesh:

Year:  1998        PMID: 9566641

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  19 in total

Review 1.  Combination therapies for systemic sclerosis.

Authors:  C P Denton; C M Black
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis.

Authors:  F Guideri; M Acampa; S Rechichi; P L Capecchi; P E Lazzerini; M Galeazzi; A Auteri; F Laghi-Pasini
Journal:  Ann Rheum Dis       Date:  2006-06       Impact factor: 19.103

3.  QT dispersion and P wave dispersion in patients with fibromyalgia.

Authors:  Servet Yolbaş; Ahmet Yıldırım; Deccane Düzenci; Bülent Karakaya; Mustafa Necati Dağlı; Süleyman Serdar Koca
Journal:  Eur J Rheumatol       Date:  2016-12-01

4.  QT dispersion in patients with systemic lupus erythematosus: the impact of disease activity.

Authors:  Javad Kojuri; Mohammad Ali Nazarinia; Mohammad Ghahartars; Yadollah Mahmoody; Gholam reza Rezaian; Lida Liaghat
Journal:  BMC Cardiovasc Disord       Date:  2012-02-27       Impact factor: 2.298

5.  QT dispersion increases in patients with systemic lupus erythematosus.

Authors:  Bunyamin Yavuz; Enver Atalar; Omer Karadag; Erol Tulumen; Necla Ozer; Ali Akdogan; Ihsan Ertenli; Sedat Kiraz; Meral Calguneri; Ferhan Ozmen
Journal:  Clin Rheumatol       Date:  2006-08-02       Impact factor: 2.980

6.  Anti-Ro52 antibody acts on the S5-pore linker of hERG to chronically reduce channel expression.

Authors:  John Szendrey; Shawn M Lamothe; Stephanie Vanner; Jun Guo; Tonghua Yang; Wentao Li; Jordan Davis; Mala Joneja; Adrian Baranchuk; Shetuan Zhang
Journal:  Cardiovasc Res       Date:  2019-08-01       Impact factor: 10.787

7.  Prolonged Tpeak-Tend interval in anti-Ro52 antibody-positive connective tissue diseases.

Authors:  Ayse Nur Tufan; Saim Sag; Mustafa Ferhat Oksuz; Selime Ermurat; Belkis Nihan Coskun; Mustafa Gullulu; Ferah Budak; Ibrahim Baran; Yavuz Pehlivan; Ediz Dalkilic
Journal:  Rheumatol Int       Date:  2016-05-18       Impact factor: 2.631

Review 8.  Arrhythmias in pulmonary arterial hypertension.

Authors:  Archana Rajdev; Hasan Garan; Angelo Biviano
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

9.  Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma.

Authors:  Orcun Ciftci; Ahmet Mesut Onat; Bunyamin Yavuz; Ali Akdogan; Kudret Aytemir; Lale Tokgozoglu; Levent Sahiner; Ali Deniz; Kemal Ureten; Guler Kizilca; Meral Calguneri; Ali Oto
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

Review 10.  Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice.

Authors:  Yaniel Castro-Torres; Raimundo Carmona-Puerta; Richard E Katholi
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.